Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.
Dividend history for Laurus Labs Limited (LAURUSLABS.NS)
Laurus Labs Limited made a total of 16 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.29
Dividend payments for Laurus Labs Limited (LAURUSLABS.NS) from 2017 to 2024
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| November 06, 24 | $0.00 | $0.00 |
| May 08, 24 | $0.00 | $0.00 |
| November 02, 23 | $0.00 | $0.00 |
| October 30, 23 | $0.00 | $0.00 |
| May 10, 23 | $0.01 | $0.01 |
| November 03, 22 | $0.01 | $0.01 |
| May 10, 22 | $0.01 | $0.01 |
| November 17, 21 | $0.01 | $0.01 |
| May 11, 21 | $0.01 | $0.01 |
| February 08, 21 | $0.00 | $0.00 |
| November 10, 20 | $0.01 | $0.01 |
| July 01, 20 | $0.06 | $0.01 |
| March 23, 20 | $0.02 | $0.00 |
| July 03, 19 | $0.09 | $0.02 |
| June 28, 18 | $0.02 | $0.00 |
| July 06, 17 | $0.02 | $0.00 |